Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Kidney shield? drug may protect young cancer patients from chemo harm

NCT ID NCT06196853

First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 34 times

Summary

This study tests whether the drug aminophylline can protect the kidneys of children receiving cisplatin chemotherapy. Twenty-four children will be randomly assigned to receive either aminophylline or a placebo alongside their standard chemo hydration. Researchers will measure kidney function and damage markers over five days to see if aminophylline helps.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Siriraj hospital, Mahidol university

    Bangkok, 10700, Thailand

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

aminophylline

What this could lead to

If it works, this could point toward a way to reduce kidney damage in children undergoing cisplatin chemotherapy.

What could go wrong

This is a very small, early-phase trial with only 24 children, so results may not be conclusive. Aminophylline can cause side effects like nausea, vomiting, and heart rhythm changes.

Conditions

The condition(s) this trial relates to.

acute kidney injury childhood malignant neoplasm renal tubule disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.